Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
AVAILABLE
NCT05619367
A Compassionate Use (CU) Program of Odronextamab
Sponsor: Regeneron Pharmaceuticals
View on ClinicalTrials.gov
Summary
Provide compassionate use of odronextamab
Key Details
Gender
All
Age Range
Any - Any
Study Type
EXPANDED_ACCESS
Enrollment
Not specified
Start Date
Not specified
Completion Date
Not specified
Last Updated
2026-10-09
Healthy Volunteers
Not specified
Conditions
Interventions
DRUG
Odronextamab